SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-086035
Filing Date
2023-08-01
Accepted
2023-08-01 07:08:55
Documents
14
Period of Report
2023-08-01
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2322453d1_8k.htm   iXBRL 8-K 31576
2 EXHIBIT 99.1 tm2322453d1_ex99-1.htm EX-99.1 13942
6 GRAPHIC tm2322453d1_ex99-1img01.jpg GRAPHIC 4865
  Complete submission text file 0001104659-23-086035.txt   234747

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA trda-20230801.xsd EX-101.SCH 3018
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE trda-20230801_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE trda-20230801_pre.xml EX-101.PRE 22361
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2322453d1_8k_htm.xml XML 3423
Mailing Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210
Business Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Filer) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40969 | Film No.: 231129630
SIC: 2834 Pharmaceutical Preparations